- What This Exam Actually Is
- Reading the ABMGG Blueprint by Weight
- The Heavy Hitters: Amino Acids, Lipids, Organic Acids, Lysosomes, Carbohydrates
- The Middle Tier: Laboratory, Cofactors, Mitochondria
- The Small Domains That Still Cost Points
- Why the Laboratory Domain Deserves Its Own Plan
- Thinking in Case Patterns, Not Isolated Facts
- A Domain-Ordered Study Schedule
- Registration, Fees, and What Is Not Publicly Verified
- Who Uses This Credential
- Frequently Asked Questions
- The exam is built on the ABMGG 2025 Biochemical Genetics Blueprint, which assigns approximate percentages to 15 content domains.
- Amino acids (15%), lipids (13%), organic acids (12%), and lysosomes (12%) together account for roughly half of the blueprint.
- The Laboratory domain is 8% of the blueprint, so analytical interpretation deserves dedicated study, not leftover time.
- Peroxisomes, purines and pyrimidines, transport, and metals are 3% each; creatine is 1%. Learn their signature disorders efficiently.
What This Exam Actually Is
Medical Biochemical Genetics is a specialty examination governed by the American Board of Medical Genetics and Genomics (ABMGG). It tests your command of inborn errors of metabolism: how a single enzyme, transporter, or cofactor defect produces a recognizable pattern of biochemical findings, clinical presentation, and management decisions. If you are still orienting yourself to the credential, our overview of what MBG certification is covers the basics before you commit to a study plan.
The content is defined by the ABMGG 2025 Biochemical Genetics Blueprint and Content Codes. That document lists the official exam content topics and their approximate percentages. It is the single most reliable map of what to study, and everything in this guide is organized around it. For a deeper walk through each content area, see the complete guide to all 15 MBG content areas.
Reading the ABMGG Blueprint by Weight
The blueprint percentages are approximate, but they tell you where the exam is likely to spend its questions. Here is the full distribution at a glance.
| Domain | Approx. Weight | Priority Tier |
|---|---|---|
| Amino acids | 15% | Heavy |
| Lipids | 13% | Heavy |
| Organic acids | 12% | Heavy |
| Lysosomes | 12% | Heavy |
| Carbohydrates | 10% | Heavy |
| Laboratory | 8% | Middle |
| Cofactors | 7% | Middle |
| Mitochondria | 7% | Middle |
| Peroxisomes | 3% | Small |
| Purines and pyrimidines | 3% | Small |
| Transport | 3% | Small |
| Metals | 3% | Small |
| Other disease category | 3% | Small |
| Neurotransmitters | 2% | Small |
| Creatine | 1% | Small |
Add up the five heavy domains and you reach 62% of the blueprint. Add Laboratory, Cofactors, and Mitochondria and you are past 80%. That does not mean the small domains are ignorable, but it does mean your time allocation should follow the weights rather than your personal comfort zones.
The Heavy Hitters: Amino Acids, Lipids, Organic Acids, Lysosomes, Carbohydrates
Amino Acids (15%)
The largest domain and the classic foundation of biochemical genetics. Expect to reason from plasma amino acid patterns back to the defective enzyme and forward to dietary and pharmacologic management.
- Phenylalanine hydroxylase deficiency and the tetrahydrobiopterin axis that connects it to the cofactor domain
- Urea cycle disorders: enzyme-by-enzyme biochemistry, ammonia and orotic acid patterns, acute crisis management
- Maple syrup urine disease, homocystinuria, tyrosinemias, and nonketotic hyperglycinemia
- Which findings distinguish disorders that look similar on a first-line screen
Lipids (13%)
This domain rewards candidates who understand pathways rather than lists. Fatty acid oxidation and the lipid storage and synthesis disorders each have characteristic metabolite signatures.
- Fatty acid oxidation disorders, including MCAD deficiency and long-chain defects, and their acylcarnitine profiles
- Carnitine cycle disorders and the clinical consequences of fasting stress
- Disorders of cholesterol synthesis and lipoprotein metabolism
- Management principles: avoiding fasting, dietary fat modification, and emergency protocols
Organic Acids (12%)
Organic acidemias are pattern-recognition heavy. You need to connect urine organic acid findings, acylcarnitine elevations, and acid-base status to a specific block in a pathway.
- Propionic and methylmalonic acidemias, including the vitamin B12 responsive and nonresponsive distinctions
- Isovaleric acidemia and other branched-chain pathway defects
- Glutaric acidemia types and the neurologic risk around metabolic decompensation
- Characteristic metabolites and the logic of carnitine and scavenger therapy
Lysosomes (12%)
Lysosomal storage disorders combine enzymology, clinical phenotype, and a growing set of therapeutic options. Questions often hinge on telling one storage disorder from another using the clinical picture plus a single discriminating test.
- Mucopolysaccharidoses, sphingolipidoses, and oligosaccharidoses grouped by substrate
- Inheritance patterns, including the X-linked members of the group
- Enzyme replacement, substrate reduction, and other disease-directed approaches
- Which urine and enzyme assays screen for which families of disorders
Carbohydrates (10%)
Glycogen storage diseases, galactosemia, hereditary fructose intolerance, and disorders of gluconeogenesis are the backbone here. Hypoglycemia workups come up repeatedly in this domain.
- Glycogen storage disease types: enzyme, tissue involvement, and distinguishing laboratory features
- Galactosemia screening, confirmation, and dietary management
- Fructose metabolism disorders and the hazard of dietary triggers
- Reading glucose, lactate, ketone, and lipid patterns together
If you want a frank read on how much recall versus reasoning these domains demand, the article on how hard the MBG exam is breaks down where candidates typically feel the pressure.
The Middle Tier: Laboratory, Cofactors, Mitochondria
These three domains are each 7 to 8% of the blueprint, but they carry outsized value because they tie together material from the heavy domains.
Cofactors (7%)
Many amino acid, organic acid, and mitochondrial disorders are modified by vitamin and cofactor status, so this domain pays off twice.
- Biotin, cobalamin, folate, and pyridoxine related disorders and their responsiveness to supplementation
- Tetrahydrobiopterin metabolism and its link to neurotransmitter synthesis
- Which clinical presentations should trigger a cofactor trial
Mitochondria (7%)
Expect questions on oxidative phosphorylation defects, pyruvate metabolism, and the diagnostic challenge of multisystem presentations.
- Lactate, pyruvate, and the lactate-to-pyruvate ratio as diagnostic clues
- Pyruvate dehydrogenase deficiency versus respiratory chain disorders
- Maternal versus nuclear inheritance implications for counseling
The Small Domains That Still Cost Points
Peroxisomes (3%), purines and pyrimidines (3%), transport (3%), metals (3%), other disease category (3%), neurotransmitters (2%), and creatine (1%) together make up about 18% of the blueprint. The efficient approach is to learn the signature disorder or two in each, then move on.
- Peroxisomes: the Zellweger spectrum, X-linked adrenoleukodystrophy, and the very-long-chain fatty acid marker connection to the lipid domain.
- Purines and pyrimidines: Lesch-Nyhan syndrome, adenosine deaminase deficiency, and the clinical contrast between overproduction and immunodeficiency presentations.
- Transport: cystinuria, Hartnup disease, and other membrane transport defects that show up as abnormal urine or plasma amino acid patterns.
- Metals: Wilson disease and Menkes disease as the paired copper disorders, plus iron and other metal handling conditions.
- Creatine: the creatine synthesis and transport disorders, which are low-yield in weight but conceptually tidy to learn.
- Neurotransmitters: disorders of neurotransmitter synthesis and metabolism, best learned alongside tetrahydrobiopterin biochemistry.
Why the Laboratory Domain Deserves Its Own Plan
At 8% of the blueprint, Laboratory is larger than several clinical domains and is easy to underprepare. It covers the analytical side of biochemical genetics: how specimens are collected, which assays are appropriate, and how to interpret results.
- Tandem mass spectrometry and acylcarnitine profiling, including what a given pattern does and does not prove
- Plasma amino acid analysis and urine organic acid analysis, with their typical pre-analytic pitfalls
- Enzyme assays versus molecular confirmation, and when each is the better next step
- Newborn screening logic: analytes, cutoffs, false positives, and follow-up testing
- Specimen handling, timing relative to fasting or illness, and sources of interference
Key Takeaway
Treat every disorder you study as a three-part unit: the clinical presentation, the laboratory signature, and the confirmatory test. Doing this as you go folds Laboratory preparation into the other 14 domains instead of leaving it as a separate cram session.
Thinking in Case Patterns, Not Isolated Facts
The blueprint is organized by disease category, but a metabolic clinician encounters patients, not chapters. Prepare accordingly. A typical scenario gives you an age, a presentation such as vomiting, lethargy, hypoglycemia, or developmental regression, and a set of laboratory values. Your job is to name the disorder, identify the next test, or choose the management step.
The public sources reviewed did not verify a specific question count or format details for this specialty examination, so avoid relying on forum claims about how many items you will face. Build skills that hold up under any format: recognizing patterns, sequencing a workup, and explaining the biochemistry behind each finding.
Build contrast tables for look-alike disorders
Candidates lose points on disorders that resemble one another. Make short side-by-side comparisons for the groups most prone to confusion:
- Urea cycle defects distinguished by orotic acid and citrulline patterns
- Organic acidemias distinguished by urine organic acid markers
- Fatty acid oxidation defects distinguished by acylcarnitine chain length
- Glycogen storage disease types distinguished by tissue involvement and lactate behavior
- Mucopolysaccharidoses distinguished by clinical features and inheritance
A Domain-Ordered Study Schedule
This is the one place for a timeline, and it is tied directly to blueprint weights. It assumes roughly eight weeks, but you can compress or stretch it. The logic is to anchor yourself in the biggest domains, add the cross-cutting material in the middle, and use the final stretch for the small domains and integration.
Amino acids and organic acids
- Work through the urea cycle, phenylalanine, branched-chain, and propionate pathways
- Build contrast tables for look-alike disorders
- Pair each disorder with its plasma amino acid or urine organic acid signature
Lipids and carbohydrates
- Fatty acid oxidation, carnitine cycle, and cholesterol synthesis disorders
- Glycogen storage diseases, galactosemia, and fructose disorders
- Practice hypoglycemia workups that integrate both domains
Lysosomes, cofactors, and mitochondria
- Group storage disorders by substrate and phenotype
- Revisit cofactor-responsive disorders from earlier weeks
- Study lactate, pyruvate, and respiratory chain evaluation
Laboratory and the small domains
- Mass spectrometry, enzyme assays, newborn screening logic
- Peroxisomes, purines and pyrimidines, transport, metals, creatine, neurotransmitters
Integration and review
- Mixed-domain case practice under timed conditions
- Re-drill the disorders you keep confusing
- Skim a one-page summary such as our MBG cheat sheet for final consolidation
Whatever pace you choose, use the MBG practice tests to expose weak domains early rather than late. Missing a question on cofactors in week two is far cheaper than discovering the gap in week eight.
Registration, Fees, and What Is Not Publicly Verified
Because several credentials share the MBG acronym, this is the section where misinformation spreads fastest. Here is what can and cannot be said responsibly about this specific exam.
- Governing body: the American Board of Medical Genetics and Genomics (ABMGG).
- Content source: the ABMGG 2025 Biochemical Genetics Blueprint and Content Codes.
- Not verified in public sources reviewed: a published question count, examination fee, pass rate, and testing provider for this specialty examination.
The same caution applies to the pass rate discussion. Without a verified public figure, any specific percentage you see circulating should be treated as unreliable.
Who Uses This Credential
Biochemical genetics expertise is applied in settings where inborn errors of metabolism are diagnosed and managed. That typically means academic medical centers with metabolic and genetics divisions, children's hospitals, and clinical laboratories that perform biochemical testing such as acylcarnitine, amino acid, and organic acid analysis. Newborn screening programs and public health laboratories also rely on this expertise.
Because the exam leans heavily on laboratory interpretation and clinical pattern recognition, it suits both clinicians who manage metabolic patients and laboratory-focused professionals who interpret biochemical results. For a closer look at career paths, see the resources on MBG jobs, the salary guide, and whether the credential is worth it for your situation.
Frequently Asked Questions
Start with amino acids (15%), then lipids (13%), organic acids (12%), and lysosomes (12%). Together with carbohydrates (10%), these five domains make up about 62% of the blueprint and provide the foundation for cofactor, mitochondrial, and laboratory material.
The public sources reviewed did not verify a question count for this specialty examination. Confirm the current format directly with ABMGG instead of relying on unofficial claims.
Yes. At approximately 8% of the blueprint, it is larger than cofactors or mitochondria. Focus on mass spectrometry, enzyme assays, newborn screening logic, and specimen considerations, and study them alongside each disorder.
It is risky. Peroxisomes, purines and pyrimidines, transport, metals, neurotransmitters, creatine, and the other disease category total about 18% of the blueprint. Learning the signature disorder in each is efficient and protects against unfamiliar questions.
The official source is the ABMGG 2025 Biochemical Genetics Blueprint and Content Codes. Use it as your master checklist, and cross-reference it with our MBG study guide and the domain breakdown as you track coverage.